Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM CL A NEW
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
214K
-
Shares change
-
+94.5K
-
Total reported value, excl. options
-
$142K
-
Value change
-
+$64.2K
-
Number of buys
-
9
-
Number of sells
-
-2
-
Price
-
$0.67
Significant Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) as of Q4 2024
20 filings reported holding HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW as of Q4 2024.
HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 214K shares
.
Largest 10 shareholders include Virtu Financial LLC (46.5K shares), Grant Private Wealth Management Inc (37.2K shares), UBS Group AG (29.5K shares), TWO SIGMA SECURITIES, LLC (26.2K shares), HRT FINANCIAL LP (23.8K shares), GEODE CAPITAL MANAGEMENT, LLC (21.5K shares), VANGUARD GROUP INC (12.6K shares), Tower Research Capital LLC (TRC) (5.57K shares), IFP Advisors, Inc (5K shares), and CITIGROUP INC (4.16K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.